Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
Clinical trial NCT00941460 · COMPLETED
Trial details
- NCT number
- NCT00941460
- Sponsor
- Prof. Dr. Wolfgang Wick
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.